Breaking News
Get 50% Off 0
🚀 Netflix soars after Q4 earnings. Catch the best Big Tech plays before they report.
Use free screener
Close

Novavax Inc (NVAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.19 +0.74    +8.76%
24/01 - Closed. Currency in EUR
Type:  Equity
Market:  Austria
ISIN:  US6700024010 
  • Volume: 0
  • Bid/Ask: 9.16 / 9.21
  • Day's Range: 8.99 - 9.19
Novavax 9.19 +0.74 +8.76%

Novavax Company Profile

 
Explore the Novavax company profile for core details about Novavax, assess Novavax company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

1543

Equity Type

ORD

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Contact Information

Address 700 Quince Orchard Road
Gaithersburg, 20878
United States
Phone 240 268 2000
Fax -

Top Executives

Name Age Since Title
John Charles Jacobs 55 2023 President, CEO & Director
Gregg Huber Alton 58 2020 Independent Director
Richard Huntington Douglas 71 2010 Independent Director
Rachel K. King 65 2018 Independent Director
David M. Mott 59 2020 Independent Director
Margaret G. McGlynn 65 2020 Independent Director
James F. Young 71 2010 Independent Chairman of the Board
Richard J. Rodgers 57 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVAX Comments

Write your thoughts about Novavax Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pravin Dand
Pravin Dand Jun 15, 2020 23:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy
Pravin Dand
Pravin Dand Jun 15, 2020 22:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy
Pravin Dand
Pravin Dand Jun 15, 2020 22:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buying huge
Tejas Desai
Tejas Desai Jun 15, 2020 22:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the reason?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email